Third quarter results increased significantly! The chain of medical giants has accelerated its national distribution

On October 26, listed ophthalmology giant Eyre Ophthalmology released its third-quarter 2020 report, which showed operating income of 4.402 billion yuan, up 47.55 percent year-on-year.
net profit attributable to shareholders of listed companies was RMB870 million, up 62.34% YoY, while net profit attributable to shareholders of listed companies, net of non-recurring profit and loss, was RMB1,002 million, up 85.49% YoY.
report also showed that net profit in the first three quarters was RMB1.55 billion, up 25.6% YoY.
is also worth noting that behind the beautiful performance list, in recent years, listed company Eyre Ophthalmology has been in a buy-to-buy state of expansion.
Eyre Ophthalmology said the company's good performance was partly due to the acquisition of 30 hospitals in June, which were included in the company's consolidated statement on July 1.
, 26 mergers and acquisitions funds involved by listed companies can achieve "seamless integration" in management, process optimization and so on.
In January 2020, the listed company Eyre Ophthalmology announced that it plans to acquire 30 ophthalmology hospitals for 1.87 billion yuan, mainly involving Tianjin Zhongsixin, Orid Vision, Xuancheng Eye Hospital, Wanzhou Ari and a total of 30 ophthalmology hospitals.
In April 2020, Eyre Ophthalmology issued shares and paid cash to purchase assets and raise supporting funds, which was approved by the CSRC, and in June the relevant subject matter asset transfer procedures and industrial and commercial change filing and registration work were completed one after another, and subsequently implemented the non-public issuance of the supporting funds raised.
According to the company's announcement, in this transaction, Eyre Ophthalmology by issuing shares and paying cash to buy 100% of Tianjin CITIC, 100% of Aled Vision, 80% of Xuancheng Eye Hospital, 90% of Aerrie, Wanzhou, and 90% of Kaizhou Aerrie, the total price of such equity transactions is 1.87 billion yuan.
, Eyre Ophthalmology raised matching funds through a non-public offering, totalling no more than 710 million yuan.
It is understood that the acquisition of the hospital is mostly rooted in the relatively limited medical resources of the third and fourth-tier cities, in the local leadership position and good brand reputation, is expected to further consolidate the layout of the company's municipal hospitals and the construction of the group's internal hierarchical diagnosis and treatment system.
An industry insider told the medical profession that over the past decade, Eyre ophthalmology practice to the industry, the government and the public to prove that the marketization of medical services is by no means a flood beast, private medical services in the field of basic medical services can not only be reliable quality, low cost, but also become the mainstream of the industry.
the opening of the first Eyre Ophthalmology Hospital in Shenyang, to the opening ceremony of a new hospital, Eyre Ophthalmology has hundreds of ophthalmology hospitals across the country.
, has previously revealed that the layout of 1,000 county-level hospitals will be completed by 2020.
the arrival of Eyre Ophthalmology, almost swept the local large hospital ophthalmology.
Professor Zhu Hengpeng, deputy director of the Institute of Economic Research of the Chinese Academy of Social Sciences and director of the Center for Public Policy Research of the Academy of Social Sciences, said that although it is difficult for private hospitals to compete with public triple-A hospitals in many diseases, in the field of ophthalmology, private medical care has defeated local triple-A hospitals in almost every city.
close on October 26, 2020, Eyre Ophthalmology has a market capitalization of nearly $200 billion, with a total market capitalization of $234.1 billion.
as a white horse stock that continues to rise in share prices, Aer Eye's market capitalization is close to the ceiling, it is estimated that even the helm of Chen Bang do not know.